SOMX released financials the day before they announced the FDA approval. Those 2 catalysts made the stock more than double. This one could very well play out the same way too. That's just me comparing it to SOMX, but in reality this company has different executives and different minds so things could ALWAYS play out differently. It's all speculation right now, but the fact remains is that we'll definitely see what Q1 looks like tomorrow morning pre-market.